Ivan Matić

6.3k citations
45 papers · 4.4k indexed · 1 hit paper · h-index 28
  • Physiology top 0.5%
  • Oncology top 1%
    • PARP inhibition in cancer therapy 14
    • Ubiquitin and proteasome pathways 14
    • RNA and protein synthesis mechanisms 8
    • Glycosylation and Glycoproteins Research 7
    • DNA Repair Mechanisms 6
  • Immunology top 5%
    • Toxin Mechanisms and Immunotoxins 13
    • Advanced Proteomics Techniques and Applications 8
    • Mass Spectrometry Techniques and Applications 5

Ivan Matić

44 papers receiving 4.4k citations

Hit Papers

A practical guide to the MaxQuant computational platform ...6412009202620142020200400600

Peers

Ivan Matić
Comparison fields: 5 of 110
  • Physiology 340
  • Oncology 1.8k
  • Molecular Biology 3.4k
  • Immunology 790
  • Parasitology 166
Replace Petra Beli with:
Petra Beli Germany
Rachel Toth United Kingdom
Masato Akutsu Germany
Sarah Maslen United Kingdom
Rein Aasland Norway
Hua Jane Lou United States
Marius K. Lemberg Germany
David B. Williams Canada
Yayoi Kimura Japan
Lucia E. Rameh United States
Ivan Matić relative to Petra Beli Germany Petra Beli's profile →
Citations per field
00.5×3.6×
Petra Beli · 1×
Citations per year

Countries citing papers authored by Ivan Matić

Since Specialization
Citations

This map shows the geographic impact of Ivan Matić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Matić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Matić more than expected).

Fields of papers citing papers by Ivan Matić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Matić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Matić. The network helps show where Ivan Matić may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ivan Matić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ivan Matić Line = papers co-authored together Ivan Matić links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20254
3 20252
4 20241
5 20245
6 202344
7 20230
8 20232
9 202224
10 202072
11 2018192
12 201885
13 2017272
14 2016190
15 2016222
16 201576
17 201414
18 2010260
19 2010133
20 2008134

About Ivan Matić

Ivan Matić is a scholar working on Physiology, Immunology, Oncology, Endocrinology and Spectroscopy, having authored 45 papers that have together received 4.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (14 papers), PARP inhibition in cancer therapy (14 papers), Toxin Mechanisms and Immunotoxins (13 papers), Advanced Proteomics Techniques and Applications (8 papers), RNA and protein synthesis mechanisms (8 papers), Glycosylation and Glycoproteins Research (7 papers), DNA Repair Mechanisms (6 papers) and Mass Spectrometry Techniques and Applications (5 papers). The work is most often cited by research in Physiology (340 citations), Oncology (1.8k citations), Molecular Biology (3.4k citations), Immunology (790 citations) and Parasitology (166 citations). Ivan Matić has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Matthias Mann, Ronald T. Hay, Michael H. Tatham, Thomas Colby, Jürgen Cox, Ivan Ahel, Juán José Bonfiglio, Maximiliane Hilger, Orsolya Leidecker and Nagarjuna Nagaraj. Their work appears in journals such as Molecular Cell, Nature Communications, Journal of Biological Chemistry, Science Signaling and Journal of Proteome Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026